4-Methyl-3-oxo-3,4-dihydro-quinoxaline-2-carboxylic acid, 95.0%, 1g

1-(3-Bromo-5-fluoropyridin-2-yl)ethanone, 97%, 250mg

Butanedioic acid, 2,3-bis[(4-methylbenzoyl)oxy]-, (2R,3R)-, compd. with ethyl (2R,3S)-2-[4-(cyclopentylamino)phenyl]-3-piperidinecarboxylate (2:1), 97%, 1g

ethyl 2-amino-4-(4-methoxyphenyl)-1,3-thiazole-5-carboxylate, 98%, 1g

Ponceau 4R, 1g

2-(4,5-Dimethoxy-2-(thiomorpholin-4-ylsulfonyl)phenyl)acetic acid, 95%, 1g

(2S,4R)-4-(Benzyloxy)-1-(tert-butoxycarbonyl)pyrrolidine-2-carboxylic acid, 95.0%, 10g

Chloromethyl Phenyl Sulfone>98.0%(GC)5g

1-Chloro-1,1-dibromo-2,2,2-trifluoroethane, 97.0%, 1g

N-Methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine dihydrochloride, 98%, 25g

2-Amino-3,4,5,6-tetrafluorobenzoic acid, 95.0%, 1g

3-Thiophenecarboxylic acid, 98.0%, 100g

4-(4-BROMO-2-METHYLPHENYL)MORPHOLINE, 97.0%, 250mg